Viewing Study NCT00660920


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-02-25 @ 9:02 PM
Study NCT ID: NCT00660920
Status: COMPLETED
Last Update Posted: 2018-05-16
First Post: 2008-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
Sponsor: Ariad Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia View
None Hematologic Malignancies View
Keywords: